A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India
Clinical trial NCT05855967 · COMPLETED
Trial details
- NCT number
- NCT05855967
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2024-08-08
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.